Target Name: HIGD1B
NCBI ID: G51751
Review Report on HIGD1B Target / Biomarker Content of Review Report on HIGD1B Target / Biomarker
HIGD1B
Other Name(s): HIG1 domain family member 1B | Protein CLST 11240 | CLST11240-15 | HIG1 hypoxia inducible domain family member 1B | HIGD1B variant 1 | HIG1B_HUMAN | HIG1 hypoxia inducible domain family member 1B, transcript variant 1 | CLST11240

HIGD1B: A Key Regulator of Cellular Processes

The HIGD1B (HIG1 domain family member 1B) protein is a key regulator of the growth and development of various tissues in the body. It is a member of the HIG1 family, which includes several similar proteins that share a conserved catalytic domain and a unique N-terminus. HIGD1B is expressed in a variety of tissues throughout the body, including the brain, pancreas, and heart, and is involved in the regulation of cell proliferation, differentiation, and survival.

One of the key functions of HIGD1B is its role in cell proliferation. It is a transcription factor that regulates the expression of target genes, and it has been shown to play a role in the regulation of cell proliferation in various tissues. For example, HIGD1B has been shown to promote the growth and survival of cancer cells, and it has been identified as a potential drug target for cancer treatment.

In addition to its role in cell proliferation, HIGD1B is also involved in the regulation of cell differentiation and plasticity. It has been shown to play a role in the regulation of neural stem cell proliferation and the development of neural networks, and it has been implicated in the regulation of stem cell self-renewal.

HIGD1B is also involved in the regulation of cell survival and stress resistance. It has been shown to play a role in the regulation of cell survival in response to stress and reactive oxygen species, and it has been identified as a potential therapeutic target for diseases that are characterized by cellular stress.

In conclusion, HIGD1B is a protein that is involved in a variety of important cellular processes in the body. Its function as a transcription factor, its involvement in cell proliferation, differentiation, and plasticity, and its role in cell survival and stress resistance make it an attractive target for drug development. Further research is needed to fully understand the mechanisms of HIGD1B's function and its potential as a therapeutic target.

Protein Name: HIG1 Hypoxia Inducible Domain Family Member 1B

The "HIGD1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HIGD1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

HIGD1C | HIGD2A | HIGD2B | High affinity cAMP-specif | High Affinity Immunoglobulin Epsilon Fc Receptor | HIKESHI | HILPDA | HILPDA-AS1 | HINFP | HINT1 | HINT1P1 | HINT2 | HINT3 | HIP1 | HIP1R | HIPK1 | HIPK1-AS1 | HIPK2 | HIPK3 | HIPK4 | HIRA | HIRIP3 | HISLA | Histamine Receptor (HR) | Histocompatibility antigen-related | Histone | Histone acetyltransferase (HAT) | Histone deacetylase | Histone H2A | Histone H2B | Histone H3 | Histone Lysine Demethylase | Histone methyltransferase | HIVEP1 | HIVEP2 | HIVEP3 | HJURP | HJV | HK1 | HK2 | HK2P1 | HK3 | HKDC1 | HLA Class II Histocompatibility Antigen DM (HLA-DM) | HLA class II histocompatibility Antigen DO (HLA-DO) | HLA class II histocompatibility antigen DP (HLA-DP) | HLA Class II Histocompatibility Antigen DQ8 | HLA class II histocompatibility antigen DR (HLA-DR) | HLA Class II Histocompatibility Antigen, DQ (HLA-DQ) | HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 | HLA complex group 16 (non-protein coding), transcript variant X2 | HLA complex group 8 | HLA-A | HLA-B | HLA-C | HLA-DMA | HLA-DMB | HLA-DOA | HLA-DOB | HLA-DPA1 | HLA-DPA2 | HLA-DPA3 | HLA-DPB1 | HLA-DPB2 | HLA-DQA1 | HLA-DQA2 | HLA-DQB1 | HLA-DQB1-AS1 | HLA-DQB2 | HLA-DRA | HLA-DRB1 | HLA-DRB2 | HLA-DRB3 | HLA-DRB4 | HLA-DRB5 | HLA-DRB6 | HLA-DRB7 | HLA-DRB8 | HLA-DRB9 | HLA-E | HLA-F | HLA-F-AS1 | HLA-G | HLA-H | HLA-J | HLA-K | HLA-L | HLA-N | HLA-P | HLA-U | HLA-V | HLA-W | HLCS | HLF | HLTF | HLX | HM13 | HMBOX1 | HMBS | HMCES